Female Sex is an Independent Predictor of Death and Bleeding Among Fibrinolytic Treated Patients With AMI

• Status: Completed
• Trial end date: 2007-10-01
• Target enrollment: 0
• Participant gender: All

Summary

This study evaluated differences between men and women in the presentation, management and outcome of heart attacks within the GUSTO V study.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: New York University School of Medicine; NYU Langone Health
• Collaborators: Centocor, Inc.; Eli Lilly and Company; The Cleveland Clinic
• Treatments: Tissue Plasminogen Activator

Criteria

Inclusion Criteria:

• inclusion into GUSTO V

Exclusion Criteria:

• lack of availability of data (database study)